Osteoarthritis Pain Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Osteoarthritis may experience signs and symptoms that can include joint-specific pain at rest or while walking/climbing stairs, pain at night, soreness to the touch of the affected joints, decreased range of motion, etc. Osteoarthritis pain drugs help to relieve the pain that occurs when a person suffers from OA.The osteoarthritis pain drugs market is segmented based on drug class, the route of administration, and dosage form.
MARKET DYNAMICS
The osteoarthritis pain drugs market is driving by factors such as osteoarthritis (OA), the most prevalent form of joint disease, affects 28 million people in the US and an estimated 4-13% of the world's population. It is the most common cause of disability in people over age 65. World Health Organization also states that worldwide estimates for Osteoarthritis report that 9.6% of men and 18.0% of women. This high prevalence creates a need for Osteoarthritis pain drugs. However, the side effects of the drugs and loss of patent exclusivity of branded therapies may confine the growth of the market.
MARKET SCOPE
The "Osteoarthritis Pain Drugs Market to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Osteoarthritis Pain Drugs Market with detailed market segmentation by product types and end user. The Osteoarthritis Pain Drugs Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Osteoarthritis Pain Drugs Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The osteoarthritis pain drugs market is segmented on the basis of drugs, route of administration, dosage form, and distribution channel. Based on drugs, the market is segmented as NSAIDs, analgesics, viscosupplements, corticosteroids, others. Based on route of administration, the market is segmented as oral, parenteral, topical. Based on dosage form, the market is segmented as solid, liquid, semi-solid. Based on distribution channel, the market is segmented as hospital pharmacies, retail pharmacies and online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Osteoarthritis Pain Drugs Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Osteoarthritis Pain Drugs Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Osteoarthritis Pain Drugs Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the Osteoarthritis Pain Drugs Market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Osteoarthritis Pain Drugs Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Osteoarthritis Pain Drugs Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Osteoarthritis Pain Drugs Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the Osteoarthritis Pain Drugs Market in these regions.
MARKET PLAYERS
The report covers key developments in the Osteoarthritis Pain Drugs Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Osteoarthritis Pain Drugs Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Osteoarthritis Pain Drugs Market in the global market. Below mentioned is the list of few companies engaged in the Inositol Market.
The report also includes the profiles of key players in osteoarthritis pain drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Sanofi
- Horizon Therapeutics PLC
- Johnson & Johnson
- GlaxoSmithKline PLC
- Bayer AG
- Abbott
- Pfizer, Inc.
- Eli Lilly
- Anika Therapeutics, Inc.
- Novartis AG
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Osteoarthritis Pain Drugs Market - By Drugs
1.3.2 Osteoarthritis Pain Drugs Market - By Route of Administration
1.3.3 Osteoarthritis Pain Drugs Market - By Dosage Form
1.3.4 Osteoarthritis Pain Drugs Market - By Distribution Channel
1.3.5 Osteoarthritis Pain Drugs Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. OSTEOARTHRITIS PAIN DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. OSTEOARTHRITIS PAIN DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. OSTEOARTHRITIS PAIN DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. OSTEOARTHRITIS PAIN DRUGS - GLOBAL MARKET OVERVIEW
6.2. OSTEOARTHRITIS PAIN DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. OSTEOARTHRITIS PAIN DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUGS
7.1. OVERVIEW
7.2. DRUGS MARKET FORECASTS AND ANALYSIS
7.3. NSAIDS
7.3.1. Overview
7.3.2. NSAIDs Market Forecast and Analysis
7.4. ANALGESICS
7.4.1. Overview
7.4.2. Analgesics Market Forecast and Analysis
7.5. VISCOSUPPLEMENTS
7.5.1. Overview
7.5.2. Viscosupplements Market Forecast and Analysis
7.6. CORTICOSTEROIDS
7.6.1. Overview
7.6.2. Corticosteroids Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. OSTEOARTHRITIS PAIN DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. PARENTERAL
8.4.1. Overview
8.4.2. Parenteral Market Forecast and Analysis
8.5. TOPICAL
8.5.1. Overview
8.5.2. Topical Market Forecast and Analysis
9. OSTEOARTHRITIS PAIN DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DOSAGE FORM
9.1. OVERVIEW
9.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
9.3. SOLID
9.3.1. Overview
9.3.2. Solid Market Forecast and Analysis
9.4. LIQUID
9.4.1. Overview
9.4.2. Liquid Market Forecast and Analysis
9.5. SEMI-SOLID
9.5.1. Overview
9.5.2. Semi-solid Market Forecast and Analysis
10. OSTEOARTHRITIS PAIN DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
10.1. OVERVIEW
10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL PHARMACIES
10.3.1. Overview
10.3.2. Hospital Pharmacies Market Forecast and Analysis
10.4. RETAIL PHARMACIES
10.4.1. Overview
10.4.2. Retail Pharmacies Market Forecast and Analysis
10.5. ONLINE PHARMACIES
10.5.1. Overview
10.5.2. Online Pharmacies Market Forecast and Analysis
11. OSTEOARTHRITIS PAIN DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Osteoarthritis Pain Drugs Market Overview
11.1.2 North America Osteoarthritis Pain Drugs Market Forecasts and Analysis
11.1.3 North America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Drugs
11.1.4 North America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Route of Administration
11.1.5 North America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Dosage Form
11.1.6 North America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Distribution Channel
11.1.7 North America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Countries
11.1.7.1 United States Osteoarthritis Pain Drugs Market
11.1.7.1.1 United States Osteoarthritis Pain Drugs Market by Drugs
11.1.7.1.2 United States Osteoarthritis Pain Drugs Market by Route of Administration
11.1.7.1.3 United States Osteoarthritis Pain Drugs Market by Dosage Form
11.1.7.1.4 United States Osteoarthritis Pain Drugs Market by Distribution Channel
11.1.7.2 Canada Osteoarthritis Pain Drugs Market
11.1.7.2.1 Canada Osteoarthritis Pain Drugs Market by Drugs
11.1.7.2.2 Canada Osteoarthritis Pain Drugs Market by Route of Administration
11.1.7.2.3 Canada Osteoarthritis Pain Drugs Market by Dosage Form
11.1.7.2.4 Canada Osteoarthritis Pain Drugs Market by Distribution Channel
11.1.7.3 Mexico Osteoarthritis Pain Drugs Market
11.1.7.3.1 Mexico Osteoarthritis Pain Drugs Market by Drugs
11.1.7.3.2 Mexico Osteoarthritis Pain Drugs Market by Route of Administration
11.1.7.3.3 Mexico Osteoarthritis Pain Drugs Market by Dosage Form
11.1.7.3.4 Mexico Osteoarthritis Pain Drugs Market by Distribution Channel
11.2. EUROPE
11.2.1 Europe Osteoarthritis Pain Drugs Market Overview
11.2.2 Europe Osteoarthritis Pain Drugs Market Forecasts and Analysis
11.2.3 Europe Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Drugs
11.2.4 Europe Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Route of Administration
11.2.5 Europe Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Dosage Form
11.2.6 Europe Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Distribution Channel
11.2.7 Europe Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Osteoarthritis Pain Drugs Market
11.2.7.1.1 Germany Osteoarthritis Pain Drugs Market by Drugs
11.2.7.1.2 Germany Osteoarthritis Pain Drugs Market by Route of Administration
11.2.7.1.3 Germany Osteoarthritis Pain Drugs Market by Dosage Form
11.2.7.1.4 Germany Osteoarthritis Pain Drugs Market by Distribution Channel
11.2.7.2 France Osteoarthritis Pain Drugs Market
11.2.7.2.1 France Osteoarthritis Pain Drugs Market by Drugs
11.2.7.2.2 France Osteoarthritis Pain Drugs Market by Route of Administration
11.2.7.2.3 France Osteoarthritis Pain Drugs Market by Dosage Form
11.2.7.2.4 France Osteoarthritis Pain Drugs Market by Distribution Channel
11.2.7.3 Italy Osteoarthritis Pain Drugs Market
11.2.7.3.1 Italy Osteoarthritis Pain Drugs Market by Drugs
11.2.7.3.2 Italy Osteoarthritis Pain Drugs Market by Route of Administration
11.2.7.3.3 Italy Osteoarthritis Pain Drugs Market by Dosage Form
11.2.7.3.4 Italy Osteoarthritis Pain Drugs Market by Distribution Channel
11.2.7.4 Spain Osteoarthritis Pain Drugs Market
11.2.7.4.1 Spain Osteoarthritis Pain Drugs Market by Drugs
11.2.7.4.2 Spain Osteoarthritis Pain Drugs Market by Route of Administration
11.2.7.4.3 Spain Osteoarthritis Pain Drugs Market by Dosage Form
11.2.7.4.4 Spain Osteoarthritis Pain Drugs Market by Distribution Channel
11.2.7.5 United Kingdom Osteoarthritis Pain Drugs Market
11.2.7.5.1 United Kingdom Osteoarthritis Pain Drugs Market by Drugs
11.2.7.5.2 United Kingdom Osteoarthritis Pain Drugs Market by Route of Administration
11.2.7.5.3 United Kingdom Osteoarthritis Pain Drugs Market by Dosage Form
11.2.7.5.4 United Kingdom Osteoarthritis Pain Drugs Market by Distribution Channel
11.2.7.6 Rest of Europe Osteoarthritis Pain Drugs Market
11.2.7.6.1 Rest of Europe Osteoarthritis Pain Drugs Market by Drugs
11.2.7.6.2 Rest of Europe Osteoarthritis Pain Drugs Market by Route of Administration
11.2.7.6.3 Rest of Europe Osteoarthritis Pain Drugs Market by Dosage Form
11.2.7.6.4 Rest of Europe Osteoarthritis Pain Drugs Market by Distribution Channel
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Osteoarthritis Pain Drugs Market Overview
11.3.2 Asia-Pacific Osteoarthritis Pain Drugs Market Forecasts and Analysis
11.3.3 Asia-Pacific Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Drugs
11.3.4 Asia-Pacific Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Route of Administration
11.3.5 Asia-Pacific Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Dosage Form
11.3.6 Asia-Pacific Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Distribution Channel
11.3.7 Asia-Pacific Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Osteoarthritis Pain Drugs Market
11.3.7.1.1 Australia Osteoarthritis Pain Drugs Market by Drugs
11.3.7.1.2 Australia Osteoarthritis Pain Drugs Market by Route of Administration
11.3.7.1.3 Australia Osteoarthritis Pain Drugs Market by Dosage Form
11.3.7.1.4 Australia Osteoarthritis Pain Drugs Market by Distribution Channel
11.3.7.2 China Osteoarthritis Pain Drugs Market
11.3.7.2.1 China Osteoarthritis Pain Drugs Market by Drugs
11.3.7.2.2 China Osteoarthritis Pain Drugs Market by Route of Administration
11.3.7.2.3 China Osteoarthritis Pain Drugs Market by Dosage Form
11.3.7.2.4 China Osteoarthritis Pain Drugs Market by Distribution Channel
11.3.7.3 India Osteoarthritis Pain Drugs Market
11.3.7.3.1 India Osteoarthritis Pain Drugs Market by Drugs
11.3.7.3.2 India Osteoarthritis Pain Drugs Market by Route of Administration
11.3.7.3.3 India Osteoarthritis Pain Drugs Market by Dosage Form
11.3.7.3.4 India Osteoarthritis Pain Drugs Market by Distribution Channel
11.3.7.4 Japan Osteoarthritis Pain Drugs Market
11.3.7.4.1 Japan Osteoarthritis Pain Drugs Market by Drugs
11.3.7.4.2 Japan Osteoarthritis Pain Drugs Market by Route of Administration
11.3.7.4.3 Japan Osteoarthritis Pain Drugs Market by Dosage Form
11.3.7.4.4 Japan Osteoarthritis Pain Drugs Market by Distribution Channel
11.3.7.5 South Korea Osteoarthritis Pain Drugs Market
11.3.7.5.1 South Korea Osteoarthritis Pain Drugs Market by Drugs
11.3.7.5.2 South Korea Osteoarthritis Pain Drugs Market by Route of Administration
11.3.7.5.3 South Korea Osteoarthritis Pain Drugs Market by Dosage Form
11.3.7.5.4 South Korea Osteoarthritis Pain Drugs Market by Distribution Channel
11.3.7.6 Rest of Asia-Pacific Osteoarthritis Pain Drugs Market
11.3.7.6.1 Rest of Asia-Pacific Osteoarthritis Pain Drugs Market by Drugs
11.3.7.6.2 Rest of Asia-Pacific Osteoarthritis Pain Drugs Market by Route of Administration
11.3.7.6.3 Rest of Asia-Pacific Osteoarthritis Pain Drugs Market by Dosage Form
11.3.7.6.4 Rest of Asia-Pacific Osteoarthritis Pain Drugs Market by Distribution Channel
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Osteoarthritis Pain Drugs Market Overview
11.4.2 Middle East and Africa Osteoarthritis Pain Drugs Market Forecasts and Analysis
11.4.3 Middle East and Africa Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Drugs
11.4.4 Middle East and Africa Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Route of Administration
11.4.5 Middle East and Africa Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Dosage Form
11.4.6 Middle East and Africa Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Distribution Channel
11.4.7 Middle East and Africa Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Osteoarthritis Pain Drugs Market
11.4.7.1.1 South Africa Osteoarthritis Pain Drugs Market by Drugs
11.4.7.1.2 South Africa Osteoarthritis Pain Drugs Market by Route of Administration
11.4.7.1.3 South Africa Osteoarthritis Pain Drugs Market by Dosage Form
11.4.7.1.4 South Africa Osteoarthritis Pain Drugs Market by Distribution Channel
11.4.7.2 Saudi Arabia Osteoarthritis Pain Drugs Market
11.4.7.2.1 Saudi Arabia Osteoarthritis Pain Drugs Market by Drugs
11.4.7.2.2 Saudi Arabia Osteoarthritis Pain Drugs Market by Route of Administration
11.4.7.2.3 Saudi Arabia Osteoarthritis Pain Drugs Market by Dosage Form
11.4.7.2.4 Saudi Arabia Osteoarthritis Pain Drugs Market by Distribution Channel
11.4.7.3 U.A.E Osteoarthritis Pain Drugs Market
11.4.7.3.1 U.A.E Osteoarthritis Pain Drugs Market by Drugs
11.4.7.3.2 U.A.E Osteoarthritis Pain Drugs Market by Route of Administration
11.4.7.3.3 U.A.E Osteoarthritis Pain Drugs Market by Dosage Form
11.4.7.3.4 U.A.E Osteoarthritis Pain Drugs Market by Distribution Channel
11.4.7.4 Rest of Middle East and Africa Osteoarthritis Pain Drugs Market
11.4.7.4.1 Rest of Middle East and Africa Osteoarthritis Pain Drugs Market by Drugs
11.4.7.4.2 Rest of Middle East and Africa Osteoarthritis Pain Drugs Market by Route of Administration
11.4.7.4.3 Rest of Middle East and Africa Osteoarthritis Pain Drugs Market by Dosage Form
11.4.7.4.4 Rest of Middle East and Africa Osteoarthritis Pain Drugs Market by Distribution Channel
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Osteoarthritis Pain Drugs Market Overview
11.5.2 South and Central America Osteoarthritis Pain Drugs Market Forecasts and Analysis
11.5.3 South and Central America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Drugs
11.5.4 South and Central America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Route of Administration
11.5.5 South and Central America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Dosage Form
11.5.6 South and Central America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Distribution Channel
11.5.7 South and Central America Osteoarthritis Pain Drugs Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Osteoarthritis Pain Drugs Market
11.5.7.1.1 Brazil Osteoarthritis Pain Drugs Market by Drugs
11.5.7.1.2 Brazil Osteoarthritis Pain Drugs Market by Route of Administration
11.5.7.1.3 Brazil Osteoarthritis Pain Drugs Market by Dosage Form
11.5.7.1.4 Brazil Osteoarthritis Pain Drugs Market by Distribution Channel
11.5.7.2 Argentina Osteoarthritis Pain Drugs Market
11.5.7.2.1 Argentina Osteoarthritis Pain Drugs Market by Drugs
11.5.7.2.2 Argentina Osteoarthritis Pain Drugs Market by Route of Administration
11.5.7.2.3 Argentina Osteoarthritis Pain Drugs Market by Dosage Form
11.5.7.2.4 Argentina Osteoarthritis Pain Drugs Market by Distribution Channel
11.5.7.3 Rest of South and Central America Osteoarthritis Pain Drugs Market
11.5.7.3.1 Rest of South and Central America Osteoarthritis Pain Drugs Market by Drugs
11.5.7.3.2 Rest of South and Central America Osteoarthritis Pain Drugs Market by Route of Administration
11.5.7.3.3 Rest of South and Central America Osteoarthritis Pain Drugs Market by Dosage Form
11.5.7.3.4 Rest of South and Central America Osteoarthritis Pain Drugs Market by Distribution Channel
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL OSTEOARTHRITIS PAIN DRUGS MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. OSTEOARTHRITIS PAIN DRUGS MARKET, KEY COMPANY PROFILES
14.1. SANOFI
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. HORIZON THERAPEUTICS PLC
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. JOHNSON AND JOHNSON
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. GLAXOSMITHKLINE PLC
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. BAYER AG
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. ABBOTT
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. PFIZER, INC
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. ELI LILLY
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. ANIKA THERAPEUTICS, INC
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. NOVARTIS AG
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. Sanofi
2. Horizon Therapeutics PLC
3. Johnson & Johnson
4. GlaxoSmithKline PLC
5. Bayer AG
6. Abbott
7. Pfizer, Inc.
8. Eli Lilly
9. Anika Therapeutics, Inc.
10. Novartis AG
11. Ferring Pharmaceuticals
12. Bioventus
13. Zimmer Biomet Holdings, Inc.
14. Fidia Farmaceutici s.p.a.
15. Flexion Therapeutics, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For